Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report

• Prif Awduron: David Starks (Awdur), Deborah Prinz (Awdur), Amy Armstrong (Awdur), Lindsay Means (Awdur), Steven Waggoner (Awdur), Robert DeBernardo (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Hindawi Limited, 2011-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Type I hypersensitivity reactions to intravenous administration of etoposide are extremely rare. Etoposide is an essential component of several chemotherapy regimens used in gynecologic oncology, and discontinuation of this drug during a course of treatment should only be due to severe patient intol...